News
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...
The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are ...
Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...
The Healthy @Reader's Digest on MSN4d
Researchers Just Found That Your Gut Could Help Diagnose a Seemingly Unconnected CancerResearchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...
This Research Topic aims to shine a spotlight on the most influential and innovative research shaping the future of cancer ...
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...
NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /CNW/ -- An estimated 20 million people are diagnosed annually with ...
Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback